River Blindness Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa
Conditions:   Onchocerciasis;   Loiasis;   Diagnoses Disease;   Neglected Diseases Interventions:   Diagnostic Test: LTS-2 DEC patch;   Diagnostic Test: Skin snips Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2019 Category: Research Source Type: clinical trials